Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;14(3):231-9.
doi: 10.5217/ir.2016.14.3.231. Epub 2016 Jun 27.

Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul

Hiroshi Nakase  1 , Bora Keum  2 , Byoung Duk Ye  3 , Soo Jung Park  4 , Hoon Sup Koo  5 , Chang Soo Eun  6
Affiliations

Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul

Hiroshi Nakase et al. Intest Res. 2016 Jul.

Erratum in

Abstract

Background/aims: Inflammatory bowel disease (IBD) management guidelines have been released from Western countries, but no adequate data on the application of these guidelines in Asian countries and no surveys on the treatment of IBD in real practice exist. Since there is a growing need for a customized consensus for IBD treatment in Asian countries, Asian Organization of Crohn's and Colitis performed a multinational survey of medical doctors who treat IBD patients in Asian countries.

Methods: A questionnaire was developed between August 2013 and November 2013. It was composed of 4 domains: personal information, IBD diagnosis, IBD treatment, and quality of IBD care. Upon completion of the questionnaire, a web-based survey was conducted between 17 March 2014 and 12 May 2014.

Results: In total, 353 medical doctors treating IBD from ten Asian countries responded to the survey. This survey data suggested a difference in available medical treatments (budesonide, tacrolimus) among Asian countries. Therapeutic strategies regarding refractory IBD (acute severe ulcerative colitis [UC] refractory to intravenous steroids and refractory Crohn's disease [CD]) and active UC were coincident, however, induction therapies for mild to moderate inflammatory small bowel CD are different among Asian countries.

Conclusions: This survey demonstrated that current therapeutic approaches and clinical management of IBD vary among Asian countries. Based on these results and discussions, we hope that optimal management guidelines for Asian IBD patients will be developed.

Keywords: A web-survey; Asia; Inflammatory bowel diseases; Treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None.

Figures

Fig. 1
Fig. 1. The treatment employed for mild to moderate extensive UC. 5-ASA, 5-aminosalicylic acid.
Fig. 2
Fig. 2. The time assessing response to intravenous steroids in acute severe UC.
Fig. 3
Fig. 3. Second-line therapies in acute severe UC when intravenous steroids fail. TNF, tumor necrosis factor.
Fig. 4
Fig. 4. Test for cytomegalovirus (CMV) and Clostridium difficile infection in a severe UC attack.
Fig. 5
Fig. 5. Induction therapy in mild to moderate inflammatory small bowel CD. 5-ASA, 5-aminosalicylic acid.
Fig. 6
Fig. 6. Combinationtherapy vs. monotherapy for remission induction in thiopurine-naïve inflammatory CD.
Fig. 7
Fig. 7. Duration of combination therapy with an anti-tumor necrosis factor (TNF) agent and thiopurine for remission induction.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asiapacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145:158–165. - PubMed
    1. Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27:1266–1280. - PubMed
    1. Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015;64:1063–1071. - PubMed
    1. Feagan BG, Macdonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2012;10:CD000543. - PubMed
    1. Minami N, Yoshino T, Matsuura M, et al. Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study. BMJ Open Gastroenterol. 2015;2:e000021. - PMC - PubMed

LinkOut - more resources